Step Pharma Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 12

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 9

Step Pharma General Information

Description

Developer of proprietary small molecule therapeutics designed for the treatment of auto-immune diseases. The company's therapeutics use a novel class of oral nucleotide synthesis inhibitors that can target CTPS1 (cytidine triphosphate synthase 1) to induce selective modulation of specific immune cell populations such as T and B cells, translating to better efficacy and an improved therapeutic index, enabling healthcare providers in proper treatment of auto-immune diseases.

Contact Information

Website
www.step-ph.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 15 Rue Louis and Auguste Lumière
  • Technoparc du Pays-de-Gex
  • 01630 Saint-Genis-Pouilly
  • France
+33 0 000 00 00 00

Step Pharma Timeline

2020202120222023
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Step Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Secondary Transaction - Private 01-Jul-2021 000.00 Completed Pre-Clinical Trials
7. Later Stage VC (Series B) 24-Mar-2021 000.00 000.00 0000 Completed Pre-Clinical Trials
6. Early Stage VC 16-Dec-2018 00.000 000.00 000.00 Completed Pre-Clinical Trials
5. Early Stage VC (Series A) 21-Nov-2017 000.00 000.00 000.00 Completed Startup
4. Early Stage VC 28-Jul-2015 00000 00.000 00.000 Completed Startup
3. Accelerator/Incubator 24-Nov-2014 00.000 Completed Startup
2. Seed Round 30-Jul-2014 $3.39M $3.39M 000.00 Completed Startup
1. Joint Venture Completed Startup
To view Step Pharma’s complete valuation and funding history, request access »

Step Pharma Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
BSA-T3 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
BSA-T2 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
ADP B 000,000 00.000000 00.00 00.00 00 00.00 0.000
Category B Preference 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Ordinary 0,000,000 00.000000 00.00 00.00 00 00.00 0.00
Series A 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Series A 2,935,873 $0.119842 $2.4 $2.4 1x $2.4 14.61%
Ordinary 1,250,000 $0.119842 $2.4 $2.4 1x $2.4 6.22%
To view Step Pharma’s complete cap table history, request access »

Step Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of proprietary small molecule therapeutics designed for the treatment of auto-immune diseases. The company's t
Drug Discovery
Saint-Genis-Pouilly, France
12 As of 2021
000.00
00000000000 000.00

000000

t aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in vol
0000 000000000
Philadelphia, PA
00 As of 0000
00000
000000000 00000

0000 0

it, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim a
0000000000000
Santa Monica, CA
0000 As of 0000
00000
00.00 0000-00-00
000000&0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Step Pharma Competitors (50)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Carisma Therapeutics Formerly VC-backed Philadelphia, PA 00 00000 000000000 00000
0000 000000 Formerly VC-backed Santa Monica, CA 0000 00000 000000&0 00000
000000000 Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
000000 Venture Capital-Backed Lebanon, NH 000 00000 0000000000 0 00000
0000000 0000000000 Venture Capital-Backed Pittsburgh, PA 00 000.00 00000000000 000.00
You’re viewing 5 of 50 competitors. Get the full list »

Step Pharma Patents

  • 32

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 13

    Granted

  • 15

    Pending

  • 000

    Expiring in next 12 mo

Step Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230020663-A1 Sulfonamide inhibitors as ctps1 inhibitors Pending 20-Sep-2019 0000000000
EP-4041723-A2 Sulfonamide derivatives as ctps1 inhibitors Pending 20-Sep-2019 0000000000
EP-4041715-A1 Sulfonamide inhibitors as ctps 1 inhibitors Pending 20-Sep-2019 0000000000
US-20230002352-A1 Sulfonamide derivatives as ctps1 inhibitors Pending 20-Sep-2019 0000000000
EP-3980410-A1 N-(4-(5-chloropyridin-3-yl)phenyl)-2-(2-(cyclopropanesulfonamido)pyrimidin-4-yl) butanamide derivatives and related compounds as human ctps1 inhibitors for the treatment of proliferative diseases Pending 04-Jun-2019 C07D401/14
To view Step Pharma’s complete patent history, request access »

Step Pharma Executive Team (12)

Name Title Board Seat Contact Info
Nicolas Marsault Chief Financial Officer
Duc Tran Chief Development Officer
Philip Beer Ph.D Chief Scientific Officer
Alain Fischer Ph.D Scientific Co-Founder & Member of Scientific Advisory Board
Sylvain Latour Scientific Co-Founder
You’re viewing 5 of 12 executive team members. Get the full list »

Step Pharma Board Members (15)

Name Representing Role Since
Adrian Senderowicz MD Self Board Member 000 0000
Alain Fischer Ph.D Step Pharma Scientific Co-Founder & Member of Scientific Advisory Board 000 0000
Erik van den Berg Self Chairman 000 0000
François Thomas Ph.D Inserm Transfert Board Member 000 0000
Jacky Vonderscher Ph.D Self Board Member 000 0000
You’re viewing 5 of 15 board members. Get the full list »

Step Pharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Step Pharma Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Hadean Ventures Venture Capital Minority 000 0000 000000 0
Sunstone Life Science Ventures Venture Capital Minority 000 0000 000000 0
Imagine Institute Corporation Minority 000 0000 000000 0
Pontifax Venture Capital Venture Capital Minority 000 0000 000000 0
Sygnature Discovery PE-Backed Company Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »

Ready to get started?

Request a free trial